BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
23.00
-0.09 (-0.39%)
May 14, 2025, 9:30 AM - Market open
BioLife Solutions Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 87.76 | 82.25 | 75.86 | 76.24 | 119.16 | 48.09 | Upgrade
|
| Revenue Growth (YoY) | 34.80% | 8.44% | -0.50% | -36.02% | 147.79% | 75.69% | Upgrade
|
| Cost of Revenue | 30.55 | 28.58 | 29.92 | 29.33 | 80.98 | 20.24 | Upgrade
|
| Gross Profit | 57.22 | 53.67 | 45.93 | 46.91 | 38.18 | 27.85 | Upgrade
|
| Selling, General & Admin | 51.48 | 50.15 | 55.97 | 44.93 | 47.67 | 21.69 | Upgrade
|
| Research & Development | 8.04 | 7.91 | 12.07 | 8.67 | 11.82 | 6.72 | Upgrade
|
| Operating Expenses | 62.27 | 60.8 | 71.57 | 57.59 | 67.7 | 31.44 | Upgrade
|
| Operating Income | -5.05 | -7.13 | -25.63 | -10.68 | -29.52 | -3.59 | Upgrade
|
| Interest Expense | -0.58 | -0.72 | -1.45 | -0.28 | -0.49 | - | Upgrade
|
| Interest & Investment Income | 0.68 | - | - | - | - | 0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.35 | 0.5 | 1.3 | 0.66 | 0.17 | 3.6 | Upgrade
|
| EBT Excluding Unusual Items | -4.6 | -7.35 | -25.78 | -10.3 | -29.84 | 0.05 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -2.77 | -1.08 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.07 | -4.07 | - | 0.7 | - | 1.32 | Upgrade
|
| Other Unusual Items | - | - | 7.31 | 4.75 | 3.58 | -1.58 | Upgrade
|
| Pretax Income | -8.68 | -11.43 | -18.47 | -4.85 | -29.03 | -1.28 | Upgrade
|
| Income Tax Expense | -0.04 | -0.04 | -0.02 | -5.24 | -20.12 | -3.26 | Upgrade
|
| Earnings From Continuing Operations | -8.64 | -11.39 | -18.45 | 0.39 | -8.91 | 1.98 | Upgrade
|
| Earnings From Discontinued Operations | -1.78 | -8.8 | -49.56 | -140.19 | - | - | Upgrade
|
| Net Income to Company | -10.41 | -20.18 | -68 | -139.81 | -8.91 | 1.98 | Upgrade
|
| Net Income | -10.41 | -20.18 | -68 | -139.81 | -8.91 | 1.98 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.16 | Upgrade
|
| Net Income to Common | -10.41 | -20.18 | -68 | -139.81 | -8.91 | 1.82 | Upgrade
|
| Shares Outstanding (Basic) | 46 | 46 | 44 | 42 | 39 | 27 | Upgrade
|
| Shares Outstanding (Diluted) | 46 | 46 | 44 | 43 | 39 | 27 | Upgrade
|
| Shares Change (YoY) | 4.90% | 5.37% | 1.50% | 11.87% | 41.01% | 40.32% | Upgrade
|
| EPS (Basic) | -0.22 | -0.44 | -1.56 | -3.29 | -0.23 | 0.07 | Upgrade
|
| EPS (Diluted) | -0.23 | -0.44 | -1.56 | -3.29 | -0.23 | -0.06 | Upgrade
|
| Free Cash Flow | 9.73 | 3.14 | -23.74 | -22.41 | -19.35 | -1.16 | Upgrade
|
| Free Cash Flow Per Share | 0.21 | 0.07 | -0.54 | -0.52 | -0.50 | -0.04 | Upgrade
|
| Gross Margin | 65.20% | 65.25% | 60.55% | 61.53% | 32.04% | 57.92% | Upgrade
|
| Operating Margin | -5.76% | -8.67% | -33.79% | -14.01% | -24.77% | -7.46% | Upgrade
|
| Profit Margin | -11.86% | -24.54% | -89.65% | -183.38% | -7.48% | 3.79% | Upgrade
|
| Free Cash Flow Margin | 11.09% | 3.81% | -31.29% | -29.39% | -16.24% | -2.42% | Upgrade
|
| EBITDA | -0.46 | -1.64 | -18.5 | -3.1 | -16.65 | 1.48 | Upgrade
|
| EBITDA Margin | -0.52% | -1.99% | -24.39% | -4.06% | -13.98% | 3.08% | Upgrade
|
| D&A For EBITDA | 4.6 | 5.49 | 7.13 | 7.58 | 12.87 | 5.07 | Upgrade
|
| EBIT | -5.05 | -7.13 | -25.63 | -10.68 | -29.52 | -3.59 | Upgrade
|
| EBIT Margin | -5.76% | -8.67% | -33.79% | -14.01% | -24.77% | -7.46% | Upgrade
|
| Revenue as Reported | 87.76 | 82.25 | 75.86 | 76.24 | 119.16 | 48.09 | Upgrade
|
| Advertising Expenses | - | 0.9 | 0.8 | 0.4 | 0.6 | 0.17 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.